BR9915648A - Benzo [de] substituted isoquinoline-1,3-diones - Google Patents
Benzo [de] substituted isoquinoline-1,3-dionesInfo
- Publication number
- BR9915648A BR9915648A BR9915648-2A BR9915648A BR9915648A BR 9915648 A BR9915648 A BR 9915648A BR 9915648 A BR9915648 A BR 9915648A BR 9915648 A BR9915648 A BR 9915648A
- Authority
- BR
- Brazil
- Prior art keywords
- benzo
- diones
- substituted isoquinoline
- substituted
- isoquinoline
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/14—Aza-phenalenes, e.g. 1,8-naphthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Patente de Invenção: <B>"BENZO [DE] ISOQUINOLINA-1,3-DIONAS SUBSTITUìDAS"<D>. Novos compostos da fórmula I onde R, R¹ e R² têm o significado indicado, e seus sais ou solvatos como antagonistas de glicoproteína IbIX.Invention Patent: <B> "BENZO [DE] ISOQUINOLINA-1,3-DIONAS SUBSTITUTED" <D>. New compounds of formula I where R, R¹ and R² have the indicated meaning, and their salts or solvates as glycoprotein antagonists IbIX.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19941398A | 1998-11-25 | 1998-11-25 | |
US39878399A | 1999-09-20 | 1999-09-20 | |
PCT/EP1999/008561 WO2000032577A2 (en) | 1998-11-25 | 1999-11-09 | Substituted benzo[de]isoquinoline-1,3-diones |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9915648A true BR9915648A (en) | 2001-08-14 |
Family
ID=26894745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9915648-2A BR9915648A (en) | 1998-11-25 | 1999-11-09 | Benzo [de] substituted isoquinoline-1,3-diones |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1144381A2 (en) |
JP (1) | JP2002537225A (en) |
KR (1) | KR20010080569A (en) |
CN (1) | CN1330638A (en) |
AU (1) | AU760136B2 (en) |
BR (1) | BR9915648A (en) |
CA (1) | CA2352045A1 (en) |
CZ (1) | CZ20011782A3 (en) |
HU (1) | HUP0104520A3 (en) |
ID (1) | ID28982A (en) |
NO (1) | NO20012544D0 (en) |
PL (1) | PL348204A1 (en) |
SK (1) | SK7022001A3 (en) |
TW (1) | TW473474B (en) |
WO (1) | WO2000032577A2 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6429212B1 (en) * | 1996-08-16 | 2002-08-06 | Ishihara Sangyo Kaisha Ltd. | Medicinal composition |
EP1088821A1 (en) * | 1999-09-28 | 2001-04-04 | Applied Research Systems ARS Holding N.V. | Pharmaceutically active sulfonamide derivatives |
EP1402890B1 (en) | 2001-06-08 | 2008-01-09 | Institute of Medicinal Molecular Design, Inc. | Sulfonamide derivatives |
US6693198B2 (en) * | 2002-04-22 | 2004-02-17 | Xanthus Life Sciences, Inc. | Amonafide salts |
US8097725B2 (en) * | 2004-12-03 | 2012-01-17 | Roche Diagnostics Operations, Inc. | Luminescent indicator dye and optical sensor |
FR2915685A1 (en) * | 2007-05-02 | 2008-11-07 | Thales Sa | New fluorescent compounds of solid state in water, with naphthalimide base, useful for allowing the grafting on transducer, which is a biological substance, in biosensor and security or explosive detectors, and as markers |
EP3348555B1 (en) | 2013-03-15 | 2020-11-25 | Alumend, LLC | Compositions and methods of using the compositions for plaque softening |
WO2014179567A2 (en) * | 2013-05-01 | 2014-11-06 | Academia Sinica | Methods and compositions for treating beta-thalassemia and sickle cell disease |
CN103450176B (en) * | 2013-08-15 | 2016-07-06 | 大连理工大学 | One class is containing 2-(4-aminophenyl) benzothiazole naphthalimide compound and application thereof |
WO2016041511A1 (en) | 2014-09-19 | 2016-03-24 | Yen-Ta Lu | Benzo-heterocyclic compounds and their applications |
CN106905237B (en) * | 2017-02-08 | 2019-05-14 | 上海师范大学 | A kind of pH and weary oxygen double-bang firecracker answer the naphthalimide ratio fluorescent probe and its synthetic method of positioning tumor cell |
CN110272388B (en) * | 2019-07-08 | 2022-06-17 | 桂林医学院 | 4-dithioformic acid piperazine-3-nitro-1, 8-naphthalimide derivative and synthesis method and application thereof |
CN110283123B (en) * | 2019-07-08 | 2022-06-17 | 桂林医学院 | 4-p-toluenesulfonyl piperazine-3-nitro-1, 8-naphthalimide derivative and synthesis method and application thereof |
CN110407865B (en) * | 2019-08-02 | 2022-04-15 | 山东师范大学 | Benzene sulfonamide structure-based compound shown as formula (I) and preparation method and application thereof |
CN111518075B (en) * | 2020-04-17 | 2023-03-28 | 西南大学 | Naphthalimide piperazine triazole compound and preparation method and application thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2423546C2 (en) * | 1974-05-15 | 1983-01-27 | Hoechst Ag, 6000 Frankfurt | Process for the preparation of 4-amino-1,8-naphthalic acid-N-arylimide compounds |
ES459497A1 (en) * | 1977-06-04 | 1978-04-16 | Made Labor Sa | N(Aminoalkyl)-naphthalimides and their derivatives |
DE3635711A1 (en) * | 1986-10-21 | 1988-04-28 | Knoll Ag | 5-NITROBENZO (DE) ISOCHINOLIN-1,3-DIONE, THEIR PRODUCTION AND USE |
ATE315397T1 (en) * | 1996-10-21 | 2006-02-15 | Allelix Biopharma | NEUROTROPHIN ANTAGONISTS FOR THE TREATMENT OF EPILEPSY, ALZHEIMER'S DISEASE AND PAIN |
AU4946697A (en) * | 1996-10-28 | 1998-05-22 | Merck Patent Gmbh | Dihydrobenzoanthracenone, -pyrimidinone or dihydronaphtoquinolinone |
-
1999
- 1999-11-09 AU AU26603/00A patent/AU760136B2/en not_active Ceased
- 1999-11-09 ID IDW00200101392A patent/ID28982A/en unknown
- 1999-11-09 JP JP2000585219A patent/JP2002537225A/en active Pending
- 1999-11-09 CA CA002352045A patent/CA2352045A1/en not_active Abandoned
- 1999-11-09 CN CN99813687A patent/CN1330638A/en active Pending
- 1999-11-09 PL PL99348204A patent/PL348204A1/en unknown
- 1999-11-09 BR BR9915648-2A patent/BR9915648A/en not_active IP Right Cessation
- 1999-11-09 KR KR1020017006547A patent/KR20010080569A/en not_active Application Discontinuation
- 1999-11-09 HU HU0104520A patent/HUP0104520A3/en unknown
- 1999-11-09 EP EP99968783A patent/EP1144381A2/en not_active Withdrawn
- 1999-11-09 CZ CZ20011782A patent/CZ20011782A3/en unknown
- 1999-11-09 WO PCT/EP1999/008561 patent/WO2000032577A2/en not_active Application Discontinuation
- 1999-11-09 SK SK702-2001A patent/SK7022001A3/en unknown
- 1999-11-24 TW TW088120540A patent/TW473474B/en not_active IP Right Cessation
-
2001
- 2001-05-23 NO NO20012544A patent/NO20012544D0/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU760136B2 (en) | 2003-05-08 |
HUP0104520A3 (en) | 2002-10-28 |
NO20012544L (en) | 2001-05-23 |
HUP0104520A2 (en) | 2002-04-29 |
CN1330638A (en) | 2002-01-09 |
CZ20011782A3 (en) | 2001-09-12 |
EP1144381A2 (en) | 2001-10-17 |
SK7022001A3 (en) | 2002-09-10 |
ID28982A (en) | 2001-07-19 |
WO2000032577A2 (en) | 2000-06-08 |
PL348204A1 (en) | 2002-05-06 |
CA2352045A1 (en) | 2000-06-08 |
TW473474B (en) | 2002-01-21 |
KR20010080569A (en) | 2001-08-22 |
NO20012544D0 (en) | 2001-05-23 |
WO2000032577A3 (en) | 2000-09-21 |
JP2002537225A (en) | 2002-11-05 |
AU2660300A (en) | 2000-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9915648A (en) | Benzo [de] substituted isoquinoline-1,3-diones | |
BR0114020A (en) | 4-amino-quinazolines | |
BR9916798A (en) | 4-arylamino, 4-aryloxy and 4-arylthio diarylamines and their derivatives as selective mek inhibitors | |
BR0215042A (en) | substituted phenyl naphthalenes as estrogenic agents | |
BR9814592A (en) | "azopolycyclic compounds condensed with aryl" | |
BR9915611A (en) | Benzo [de] substituted isoquinoline-1,3-diones | |
DE69628804D1 (en) | Substituted heterocyclic derivatives as CRF antagonists | |
DE69914393D1 (en) | Pseudo-differential signaling scheme from several agents | |
BR9902086A (en) | Pharmaceutical formulations. | |
ATE295355T1 (en) | TRIS-SUBSTITUTED 1,3,5-TRIAZINE DERIVATIVES FOR THE TREATMENT OF HIV INFECTIONS | |
PT94568A (en) | SUBSTITUTED CHINAZOLINONES AS ANGIOTENSIN II ANTAGONISTS | |
TR200200579T2 (en) | Amino-thyrazolpyridine derivatives. | |
DE69917790D1 (en) | 4-AMINO SUBSTITUTED -2-SUBSITUTE-1,2,3,4-TETRAHYDROCHINOLINE AS CETP INHIBITORS | |
BR9901491A (en) | 7-hetero-bicycles [2.2.1] - heptanes. | |
DE69716925T2 (en) | ISOXAZOLINE DERIVATIVES AND THEIR USE AS ANTIMICROBE | |
BR0017010A (en) | Antibacterial agents 3-aminoquinazolin-2,4-dione | |
GR3036887T3 (en) | Meta-substituted phenylene sulphonamide derivatives | |
NO991974D0 (en) | 5-HT1F agonists | |
DE69710182D1 (en) | USE OF TETRAHYDROBETACARBOLIN DERIVATIVES FOR PREVENTING METASTASIS | |
BR0115318A (en) | (Dihydro) isoquinoline derivatives as phosphodiesterase inhibitors | |
BR0110024A (en) | Antitumor ecteinascidin derivatives | |
DE69813605D1 (en) | benzofuran | |
TR199801268T2 (en) | 3-Azetidinylalkylpiperidines or pyrrolidines as tachykinin antagonists. | |
DE69819525D1 (en) | ACRIDINE DERIVATIVES FOR IMPROVING THE ORAL BIAVAILABILITY OF TAXOL | |
NO306116B1 (en) | New benzothiadiazine compound and pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5O, 6O, 7O E 8O ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007. |